Table 3.

Outputs for $S_j,R_j,Q_j$ and rank (BP case)

Anticancer drugs	$S_j$	$R_j$	$Q_j$	BP QSPR VIKOR rank
Alpelisib	0.577194	0.245993	0.580896	13
Azacitidine	0.763794	0.348169	0.862527	18
Cytarabine	0.772701	0.35365	0.876849	19
Daunorubicin	0.449734	0.172333	0.382896	7
Dexamethasone	0.580471	0.249917	0.588943	14
Docetaxel	0.181172	0.056501	0.023011	3
Doxorubicin	0.440856	0.167141	0.369015	6
Glasdegib	0.638289	0.275422	0.667248	16
Gilteritinib	0.483351	0.184578	0.424662	8
Ivosidenib	0.431445	0.159721	0.35151	5
Midostaurin	0.337441	0.112607	0.215977	4
Olaparib	0.561948	0.232056	0.549752	11
Paclitaxel	0.148864	0.06	0.005093	1
Palbociclib	0.553575	0.226845	0.536202	10
Pamidronic acid	0.814134	0.381662	0.947135	20
Prednisone	0.606037	0.26486	0.628902	15
Ribociclib	0.569449	0.235444	0.560025	12
Tioguanine	0.850882	0.4	1	21
Toremifene	0.652638	0.280399	0.684712	17
Tucatinib	0.493892	0.194113	0.44605	9
Venetoclax	0.169572	0.057026	0.015513	2
$S_{+},R_{+}$	0.148864	0.056501
$S_{-},R_{-}$	0.850882	0.4